GENOMICS

We took genome sequencing from $3 billion to $200. That's not cost reduction — that's a revolution.

Genome sequencing plus cancer screening equals personalized medicine. We're building that future.

If we can sequence a patient's tumor and their blood in real time and have a treatment decision by the next morning, we will save lives. That is the system we are building.